Roman Rubio, MD.
Senior Vice President, Clinical Development
Dr. Rubio joined Revance in March of 2016 and leads clinical development for Revance’s aesthetic and therapeutic programs. Dr. Rubio brings more than 15 years of clinical development experience to Revance, having extensive knowledge and skill leading development efforts across numerous indications and drug delivery platforms. Prior to Revance, Dr. Rubio held leadership positions at Avalanche Biotechnologies, as well as Genentech, where he spent more than 11 years ascending numerous clinical and development management roles; most recently he served as the Global Head of Ophthalmology. In this role, Dr. Rubio led the development and medical affairs efforts for Lucentis®, resulting in the approval of the anti-VEGF therapy in diabetic macular edema and retinal vein occlusion. Dr. Rubio received an MBA in Health Care Management and Finance from The Wharton School, University of Pennsylvania, and his Doctor of Medicine from University of California, San Francisco. Additionally, Dr. Rubio holds a Master of Science, Health and Medical Sciences from the University of California, Berkeley, as well as a Bachelor of Science, Biological Sciences from the University of Notre Dame.